KURA
NASDAQ
$10.68
Kura Oncology Inc (KURA)
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops drugs for the treatment of cancer in the United States. The company is headquartered in San Diego, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $31.17 (+191.85%)
Market Cap
$1.01B
Free Cash Flow Yield
-8.40%
Beta (5Y)
1.06
Price Chart
Valuation
Market Cap$1.01B
P/S13.93
P/B9.25
Profitability
Total Revenue (TTM)$72M
Gross Profit (TTM)-$189M
EBITDA-$317M
Operating Margin-431.5%
EPS-$3.36
Financial Health
Debt-to-Equity9%
Free Cash Flow Yield-8.40%
Growth & Risk
EPS 5Y CAGR+15.40%
FCF 5Y CAGR+1.04%
Beta (5Y)1.06
Sharpe Ratio1.03